Range Impact

RNGE · OTC

$0.5301−$0.0231 (−4.18%)TodayMarket closed ·
Prev close $0.5532

About RNGE

Range Impact, Inc. engages in unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders. The company is headquartered in Cleveland, Ohio. The company went IPO on 2012-03-01. The firm owns and operates several complementary operating businesses focused on developing long-term solutions to environmental, social, and health challenges, with a particular focus on acquiring, reclaiming and repurposing mine sites and other undervalued land in economically disadvantaged communities throughout Appalachia. Its Range Land segment is focused on acquiring former mine lands with the goal of reclaiming and repurposing the sites for non-fossil fuel uses, including commercial, industrial, residential and recreational developments, with a particular focus on renewable energy facilities, agricultural installations, and projects focused on improving the quality and condition of its air, land and waterways. The Range Services segment provides environmental and operational support services to help reclaim and repurpose former mine land into next generation uses.

Employees
10
Headquarters
CLEVELAND, Ohio
Listed
Mar 1, 2012
Sector
Industrials
Industry
Commercial Services & Supplies

RNGE key statistics

Market cap
65.59M
Price-earnings ratio
5.87
Dividend yield
—
Average volume
28.17K
Volume
44.13K
Open price
$0.5885
High today
$0.60
Low today
$0.5301
52 Week high
$0.99
52 Week low
$0.12

Range Impact (RNGE) at a glance

As of Oct 20, 2026, Range Impact (RNGE) shares are priced at $0.5301, giving the company a market cap of 65.59M and a price-to-earnings ratio of 5.87.

Today the stock has traded between $0.5301 and $0.60. The current price is 0.0% above the day's low and 11.6% below its high.

Volume so far is 44.13K shares, above the average of 28.17K shares a day.

Over the past year Range Impact has ranged from $0.12 to $0.99, and now sits 47% of the way up that range.

Range Impact met or beat analyst EPS estimates in 1 of the last 2 quarters. In Q2 FY26 it reported -$0.02 per share against an estimate of $0.00.

RNGE earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 1 of the last 2 quarters, by 0.0% on average.

  1. Q4 FY25: reported $0.15 per share against an estimate of $0.00
  2. Q2 FY26: reported -$0.02 per share against an estimate of $0.00

Similar companies

Companies in the same industry as Range Impact

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.